Marshall Urist Royalty Pharma PLC (RPRX) insider trading activity

Marshall Urist is EVP, Research & Investments of Royalty Pharma plc. Currently has a direct ownership of 83,151 shares of RPRX, which is worth approximately $3.04 Million. The most recent transaction as insider was on May 08, 2025, when has been sold 36,484 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.2K

78.18% 3M change

78.18% 12M change

Total Value Held $3.04 Million

Marshall Urist Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 08 2025	BUY Grant, award, or other acquisition	-	36,484 Added 30.5%	83,151 Class A Ordinary Shares
Feb 22 2023	SELL Open market or private sale	$870,320 $37.3 p/Share	23,333 Reduced 33.33%	46,667 Class A Ordinary Shares
Feb 17 2023	BUY Conversion of derivative security	-	70,000 Added 50.0%	70,000 Class A Ordinary Shares
Jul 26 2022	SELL Open market or private sale	$852,509 $43.2 p/Share	19,734 Reduced 100.0%	0 Class A Ordinary Shares
Jul 25 2022	SELL Open market or private sale	$154,980 $43.05 p/Share	3,600 Reduced 15.43%	19,734 Class A Ordinary Shares
Jun 24 2022	SELL Open market or private sale	$1,007,752 $43.19 p/Share	23,333 Reduced 50.0%	23,334 Class A Ordinary Shares
May 16 2022	SELL Open market or private sale	$929,820 $39.85 p/Share	23,333 Reduced 33.33%	46,667 Class A Ordinary Shares
May 11 2022	BUY Conversion of derivative security	-	70,000 Added 50.0%	70,000 Class A Ordinary Shares
Jun 07 2021	SELL Open market or private sale	$779,027 $47.02 p/Share	16,568 Reduced 100.0%	0 Class A Ordinary Shares
Jun 04 2021	SELL Open market or private sale	$747,624 $45.13 p/Share	16,566 Reduced 50.0%	16,568 Class A Ordinary Shares
Jun 02 2021	SELL Open market or private sale	$604,780 $41.52 p/Share	14,566 Reduced 30.54%	33,134 Class A Ordinary Shares
May 21 2021	SELL Open market or private sale	$4,100 $41.0 p/Share	100 Reduced 0.21%	47,700 Class A Ordinary Shares
May 20 2021	SELL Open market or private sale	$78,052 $41.08 p/Share	1,900 Reduced 3.82%	47,800 Class A Ordinary Shares
May 07 2021	BUY Conversion of derivative security	-	49,700 Added 50.0%	49,700 Class A Ordinary Shares

Marshall Urist

EVP, Research & Investments

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Royalty Pharma plc

Track Activities on RPRX

Account